STACY WRIGHT: Open Payments
NPI 1568098333 · CAPE CORAL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$573 in 24 payments from 11 companies in 2025. Trend: 2023 $519 · 2024 $413 · 2025 $573
Food & beverage: $573
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $125 |
| GlaxoSmithKline, LLC. | 5 | $93 |
| ABBVIE INC. | 4 | $72 |
| Amgen Inc. | 3 | $54 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $52 |
| Lilly USA, LLC | 3 | $52 |
| AstraZeneca Pharmaceuticals LP | 1 | $31 |
| PFIZER INC. | 2 | $31 |
| Novo Nordisk Inc | 1 | $29 |
| Dexcom, Inc. | 1 | $17 |
Products named: JARDIANCE, TRELEGY ELLIPTA, Kerendia, EVENITY, MOUNJARO, UBRELVY, FARXIGA, PAXLOVID.
Industry payments across FL — which companies pay providers there.
